Crnobarić, C.

Link to this page

Authority KeyName Variants
5f0baf1e-3e65-458f-98c5-27aad22c5990
  • Crnobarić, C. (1)
Projects
No records found.

Author's Bibliography

Parameters of oxidative stress and antioxidative protection in patients with schizophrenia

Miljević, Čedo D.; Crnobarić, C.; Vidović, Bojana; Đorđević, Brižita; Lecić-Tosevski, Dušica

(Elsevier Science BV, Amsterdam, 2011)

TY  - CONF
AU  - Miljević, Čedo D.
AU  - Crnobarić, C.
AU  - Vidović, Bojana
AU  - Đorđević, Brižita
AU  - Lecić-Tosevski, Dušica
PY  - 2011
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/1502
PB  - Elsevier Science BV, Amsterdam
C3  - European Neuropsychopharmacology
T1  - Parameters of oxidative stress and antioxidative protection in patients with schizophrenia
VL  - 21
IS  - Supplement 3
SP  - S467
EP  - S467
DO  - 10.1016/S0924-977X(11)70757-X
ER  - 
@conference{
author = "Miljević, Čedo D. and Crnobarić, C. and Vidović, Bojana and Đorđević, Brižita and Lecić-Tosevski, Dušica",
year = "2011",
publisher = "Elsevier Science BV, Amsterdam",
journal = "European Neuropsychopharmacology",
title = "Parameters of oxidative stress and antioxidative protection in patients with schizophrenia",
volume = "21",
number = "Supplement 3",
pages = "S467-S467",
doi = "10.1016/S0924-977X(11)70757-X"
}
Miljević, Č. D., Crnobarić, C., Vidović, B., Đorđević, B.,& Lecić-Tosevski, D.. (2011). Parameters of oxidative stress and antioxidative protection in patients with schizophrenia. in European Neuropsychopharmacology
Elsevier Science BV, Amsterdam., 21(Supplement 3), S467-S467.
https://doi.org/10.1016/S0924-977X(11)70757-X
Miljević ČD, Crnobarić C, Vidović B, Đorđević B, Lecić-Tosevski D. Parameters of oxidative stress and antioxidative protection in patients with schizophrenia. in European Neuropsychopharmacology. 2011;21(Supplement 3):S467-S467.
doi:10.1016/S0924-977X(11)70757-X .
Miljević, Čedo D., Crnobarić, C., Vidović, Bojana, Đorđević, Brižita, Lecić-Tosevski, Dušica, "Parameters of oxidative stress and antioxidative protection in patients with schizophrenia" in European Neuropsychopharmacology, 21, no. Supplement 3 (2011):S467-S467,
https://doi.org/10.1016/S0924-977X(11)70757-X . .